Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Han Witjes
Meta‐analyses of Clinical Efficacy of Risankizumab and Adalimumab in Chronic Plaque Psoriasis: Supporting Evidence of Risankizumab Superiority
Clinical Pharmacology and Therapeutics
Pharmacology
Corifollitropin Alfa or rFSH Treatment Flexibility Options for Controlled Ovarian Stimulation: A Post Hoc Analysis of the Engage Trial
Reproductive Biology and Endocrinology
Gynecology
Endocrinology
Reproductive Medicine
Developmental Biology
Obstetrics
Related publications
Risankizumab vs. Ustekinumab for Plaque Psoriasis
British Journal of Dermatology
Dermatology
Medicine
Risankizumab for the Treatment of Plaque Psoriasis in Adults
Prescriber
Pharmacology
Risankizumab Versus Ustekinumab for Plaque Psoriasis: A Critical Appraisal
British Journal of Dermatology
Dermatology
Medicine
Efficacy and Safety of Continuous Risankizumab Therapy vs Treatment Withdrawal in Patients With Moderate to Severe Plaque Psoriasis
JAMA Dermatology
Dermatology
Medicine
Exposure‐Response Relationships for Efficacy and Safety of Risankizumab in Phase 2 and 3 Trials in Psoriasis Patients
Clinical Pharmacology and Therapeutics
Pharmacology
Lack of Effect of 12-Week Treatment With Risankizumab on the Pharmacokinetics of Cytochrome P450 Probe Substrates in Patients With Moderate to Severe Chronic Plaque Psoriasis
Clinical Pharmacokinetics
Pharmacology
Long-Term Safety of Adalimumab in Adult Patients With Plaque Psoriasis
British Journal of Dermatology
Dermatology
Medicine
Comparability of Trial Populations in Network Meta-Analyses Assessing Biologic Treatments in Moderate to Severe Plaque Psoriasis
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Long-Term Efficacy of Etanercept for Plaque-Type Psoriasis and Estimated Cost in Daily Clinical Practice
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
